Form 8-K - Current report:
SEC Accession No. 0001493152-25-009379
Filing Date
2025-03-06
Accepted
2025-03-06 16:03:35
Documents
16
Period of Report
2025-03-06
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41915
2 ex16-1.htm EX-16.1 6735
3 ex16-1_001.jpg GRAPHIC 19294
4 ex16-1_002.jpg GRAPHIC 3147
  Complete submission text file 0001493152-25-009379.txt   247520

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gcan-20250306.xsd EX-101.SCH 3009
6 XBRL LABEL FILE gcan-20250306_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE gcan-20250306_pre.xml EX-101.PRE 22355
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3236
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56027 | Film No.: 25715148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)